Report ID: SQMIG35H2039
Report ID:
SQMIG35H2039 |
Region:
Global |
Published Date: July, 2024
Pages:
165
|
Tables:
66 |
Figures:
75
Global Recombinant Proteins Market size was valued at around USD 2.20 billion in 2022 and is expected to rise from USD 2.36 billion in 2023 to reach a value of USD 4.11 billion by 2031, at a CAGR of 7.2% over the forecast period (2024–2031).
The global recombinant protein market size is projected to rise at a high CAGR between 2023 and 2030. The genetic level of recombinant proteins proceeds with the isolation of coding sequence for the target protein and its cloning into an expression plasmid vector. The majority of therapeutic recombinant proteins are produced in microbes, yeast, or animal cells in culture. Studying protein-protein interactions requires the use of recombinant proteins. Detergents, beauty products, food supplements, food manufacturing, diagnostics, vaccinations, and therapies are just a few of the applications for these proteins.
Rise in the healthcare organizations investment in research and development activities, growing frequency of chronic illnesses, and a spike in the range of regulatory bodies ought to reduce viral infections are the primary factors towards the growth of the global recombinant protein market.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35H2039